W. P. Carey Inc. Increases Quarterly Dividend to $1.005 per Share
Get Alerts WPC Hot Sheet
Join SI Premium – FREE
NEW YORK, Sept. 20, 2017 /PRNewswire/ -- W. P. Carey Inc. (NYSE: WPC) reported today that its Board of Directors increased its quarterly cash dividend to $1.005 per share, equivalent to an annualized dividend rate of $4.02 per share. The dividend is payable on October 16, 2017 to stockholders of record as of October 2, 2017.
W. P. Carey Inc.
W. P. Carey Inc. is a leading internally-managed net lease REIT that provides long-term sale-leaseback and build-to-suit financing solutions primarily for companies in the U.S. and Europe. At June 30, 2017, the Company had an enterprise value of approximately $11.2 billion. In addition to its owned portfolio of diversified global real estate, W. P. Carey manages a series of investment programs with assets under management of approximately $13.2 billion. Its corporate finance-focused credit and real estate underwriting process is a constant that has been successfully leveraged across a wide variety of industries and property types. Furthermore, its portfolio of long-term leases with creditworthy tenants has an established history of generating stable cash flows, enabling it to deliver consistent and rising dividend income to investors for over four decades. www.wpcarey.com
Institutional Investors: Peter Sands W. P. Carey Inc. 212-492-1110 [email protected]
Individual Investors: W. P. Carey Inc. 212-492-8920 [email protected]
Press Contact: Guy Lawrence Ross & Lawrence 212-308-3333 [email protected]

View original content with multimedia:http://www.prnewswire.com/news-releases/w-p-carey-inc-increases-quarterly-dividend-to-1005-per-share-300523146.html
SOURCE W. P. Carey Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean completes $1.25B senior unsecured notes offering
- CoreAgeRx Launches Advanced Preventive Longevity Protocols Featuring Microdosing Semaglutide, Microdosing Tirzepatide, and Sermorelin Therapies
- CoreAge Rx Expands Weight & Metabolic Health Offerings with Affordable, Doctor-Guided Semaglutide and Tirzepatide Programs
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share